Complexities of assessing the disease burden attributable to leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 2, Issue 10, 2008, Pages

  Bern, Caryn ^a   Maguire, James H ^b   Alvar, Jorge ^c  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTILEISHMANIAL AGENT; ANTIMONY DERIVATIVE;

AFGHANISTAN; ASIA; CARDIOTOXICITY; CLINICAL FEATURE; DEVELOPING COUNTRY; DISEASE CARRIER; DRUG COST; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LEISHMANIASIS; MANDATORY REPORTING; MIXED INFECTION; MORTALITY; NONHUMAN; PARASITE TRANSMISSION; REVIEW; SKIN LEISHMANIASIS; SOUTH AND CENTRAL AMERICA; SOUTH ASIA; VISCERAL LEISHMANIASIS; ZOONOSIS; ANIMAL; HEALTH; INFECTION CONTROL; LEISHMANIA; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; COMMUNICABLE DISEASE CONTROL; HUMANS; LEISHMANIA; LEISHMANIASIS; WORLD HEALTH;

EID: 56149121336     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000313     Document Type: Review

References (115)

1. Jeronimo SMB, de Queiroz Sousa A, Pearson RD (2006) Leishmaniasis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. Edinburgh, Scotland: Churchill Livingstone Elsevier. pp 1095-1113.
2. World Health Organization (1990) Control of the leishmaniases. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 793: 1-158.
3. Yamey G, Torreele E (2002) The world's most neglected diseases [editorial]. British Medical Journal 325: 176-177.
4. Alvar J, Yactayo S, Bern C (2006) Leishmaniasis and poverty. Trends Parasitol 22: 552-557.
5. Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: The global burden of disease framework. PLoS Negl Trop Dis 1: E114. doi:10.1371/journal.pntd.0000114.
6. Murray HW (2004) Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg 71: 787-794.
7. Reyburn H, Ashford R, Mohsen M, Hewitt S, Rowland M (2000) A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan. Trans R Soc Trop Med Hyg 94: 361-366.
8. Bern C, Joshi AR, Jha SN, Das ML, Hightower A, et al. (2000) Factors associated with visceral leishmaniasis in Nepal: Bed-net use is strongly protective. American Journal of Tropical Medicine and Hygiene 63: 184-188.
9. Bern C, Hightower AW, Chowdhury R, Ali M, Amann J, et al. (2005) Risk factors for kala-azar in Bangladesh. Emerging Infectious Diseases 11: 655-662.
10. Ritmeijer K, Davies C, van Zorge R, Wang SJ, Schorscher J, et al. (2007) Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan. Trop Med Int Health 12: 404-414.
11. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, et al. (2006) Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria. PLoS Med 3: E102. doi:10.1371/journal.pmed.0030102.
12. Bern C, Chowdhury R (2006) The epidemiology of visceral leishmaniasis in Bangladesh: Prospects for improved control. Indian J Med Res 123: 275-288.
13. Alvar J, Aparicio P, Aseffa A, den Boer M, Cañavate C, et al. (2008) The Relationship between Leishmaniasis and AIDS: The second 10 years. Clin Microbiol Rev 21: 334-359.
14. Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, et al. (1987) Malnutrition as a risk factor for severe visceral leishmaniasis. Journal of Infectious Diseases 156: 1030-1033.
15. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, et al. (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7: 581-596.
16. Marsden PD (1986) Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 80: 859-876.
17. Pagliano P, Carannante N, Rossi M, Gramiccia M, Gradoni L, et al. (2005) Visceral leishmaniasis in pregnancy: A case series and a systematic review of the literature. J Antimicrob Chemother 55: 229-233.
18. Desjeux P (1996) Leishmaniasis. Public health aspects and control. Clin Dermatol 14: 417-423.
19. Sengupta PC (1947) History of kala-azar in India. Indian Medical Gazette 82: 281-286.
20. Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, et al. (2004) Conflict and kala-azar: Determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38: 612-619.
21. Rey LC, Martins CV, Ribeiro HB, Lima AA (2005) American visceral leishmaniasis (kala-azar) in hospitalized children from an endemic area. J Pediatr (Rio J) 81: 73-78.
22. Ramesh V (1995) Post-kala-azar dermal leishmaniasis. International Journal of Dermatology 34: 85-91.
23. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM (2003) Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3: 87-98.
24. ICDDRB (2007) Post kala-azar dermal leishmaniasis: New observations challenge previous assumptions. Health and Science Bulletin 5: 6-12.
25. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, et al. (1997) Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clin Microbiol Rev 10: 298-319.
26. Desjeux P (2004) Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
27. Modabber F, Buffet PA, Torreele E, Milon G, Croft SL (2007) Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006. Kinetoplastid Biol Dis 6: 3.
28. Patz JA, Graczyk TK, Geller N, Vittor AY (2000) Effects of environmental change on emerging parasitic diseases. Int J Parasitol 30: 1395-1405.
29. Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, et al. (2003) Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis 9: 727-729.
30. Addy M, Nandy A (1992) Ten years of kala-azar in west Bengal, Part 1. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ 70: 341-346.
31. Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, et al. (2007) The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg 76: 909-914.
32. Costa CH, Stewart JM, Gomes RB, Garcez LM, Ramos PK, et al. (2002) Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 66: 334-337.
33. Murray C, Lopez A, eds. (1996) Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press.
34. Ashford RW, Desjeux P, deRaadt P (1992) Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitology Today 8: 104-105.
35. Desjeux P (1991) Information on the epidemiology and control of the leishmaniases by country or territory. Geneva: World Health Organization. pp 1-47.
36. Singh SP, Reddy DC, Rai M, Sundar S (2006) Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health 11: 899-905.
37. Copeland HW, Arana BA, Navin TR (1990) Comparison of active and passive case detection of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 43: 257-259.
38. Bora D, Singh J, Bhattacharjee J, Kureel VR, Singh S, et al. (1994) An estimate of kala azar in 1991 in district Vaishali and Bihar. J Commun Dis 26: 120-122.
39. Collin SM, Coleman PC, Ritmeijer K, Davidson RN (2006) Unseen Kala-azar deaths in south Sudan (1999-2002). Trop Med Int Health 11: 509-512.
40. Barnett P, Singh SP, Bern C, Hightower AW, Sundar S (2005) Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. American Journal of Tropical Medicine and Hygiene 73: 720-725.
41. World Health Organization (2002) Global Burden of Disease Estimates. Geneva: WHO.
42. Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, et al. (2007) Kala-azar outbreak in Libo Kemkem, Ethiopia: Epidemiologic and parasitologic assessment. Am J Trop Med Hyg 77: 275-282.
43. Bucheton B, Kheir MM, El-Safi SH, Hammad A, Mergani A, et al. (2002) The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 4: 1449-1457.
44. Elnaiem DA, Connor SJ, Thomson MC, Hassan MM, Hassan HK, et al. (1998) Environmental determinants of the distribution of Phlebotomus orientalis in Sudan. Ann Trop Med Parasitol 92: 877-887.
45. Gebre-Michael T, Lane RP (1996) The roles of Phlebotomus martini and P.celiae (Diptera: Phlebotominae) as vectors of visceral leishmaniasis in the Aba Roba focus, southern Ethiopia. Med Vet Entomol 10: 53-62.
46. Ashford RW (2000) The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol 30: 1269-1281.
47. Pratlong F, Dereure J, Bucheton B, El-Saf S, Dessein A, et al. (2001) Sudan: The possible original focus of visceral leishmaniasis. Parasitology 122: 599-605.
48. Elnaiem DA, Hassan HK, Ward RD (1997) Phlebotomine sandflies in a focus of visceral leishmaniasis in a border area of eastern Sudan. Ann Trop Med Parasitol 91: 307-318.
49. Seaman J, Mercer AJ, Sondorp E (1996) The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: Course and impact from 1984 to 1994. Int J Epidemiol 25: 862-871.
50. Elnaiem DA, Hassan MM, Maingon R, Nureldin GH, Mekawi AM, et al. (2001) The Egyptian mongoose, Herpestes ichneumon, is a possible reservoir host of visceral leishmaniasis in eastern Sudan. Parasitology 122: 531-536.
51. Dereure J, El-Safi SH, Bucheton B, Boni M, Kheir MM, et al. (2003) Visceral leishmaniasis in eastern Sudan: Parasite identification in humans and dogs; host-parasite relationships. Microbes Infect 5: 1103-1108.
52. Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243.
53. Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, et al. (1991) Kala-azar in displaced people from southern Sudan: Epidemiological, clinical and therapeutic findings. Trans R Soc Trop Med Hyg 85: 365-369.
54. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, et al. (2001) Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun 69: 4709-4718.
55. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, et al. (1986) A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154: 639-649.
56. Marlet MV, Wuillaume F, Jacquet D, Quispe KW, Dujardin JC, et al. (2003) A neglected disease of humans: A new focus of visceral leishmaniasis in Bakool, Somalia. Trans R Soc Trop Med Hyg 97: 667-671.
57. Raguenaud ME, Jansson A, Vanlerberghe V, Van der Auwera G, Deborggraeve S, et al. (2007) Epidemiology and Clinical Features of Patients with Visceral Leishmaniasis Treated by an MSF Clinic in Bakool Region, Somalia, 2004-2006. PLoS Negl Trop Dis 1: E85. doi:10.1371/ journal.pntd.0000085..
58. Boussery G, Boelaert M, van Peteghem J, Ejikon P, Henckaerts K (2001) Visceral leishmaniasis (kala-azar) outbreak in Somali refugees and Kenyan shepherds, Kenya. Emerg Infect Dis 7: 603-604.
59. Marlet MV, Sang DK, Ritmeijer K, Muga RO, Onsongo J, et al. (2003) Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. Trans R Soc Trop Med Hyg 97: 515-518.
60. Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Basal SD, et al. (2007) Neglected diseases, civil conflicts, and the right to health. Lancet 370: 619-627.
61. Reithinger R, Coleman PG (2007) Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: Cost-effectiveness of an operational program in a complex emergency setting. BMC Infect Dis 7: 3.
62. Reyburn H, Rowland M, Mohsen M, Khan B, Davies C (2003) The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: 'bringing down the neighbourhood'. Trans R Soc Trop Med Hyg 97: 170-176.
63. World Health Organization. Report of the 5th Consultative Meeting on Leishmania/HIV Coinfection. WHO Technical Report Series WHO/CDS/ NTD/IDM/2007.5.; 2007 20-22 March 2007; Addis Ababa, Ethiopia.
64. Lyons S, Veeken H, Long J (2003) Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health 8: 733-739.
65. Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, et al. (2006) A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis 43: 357-364.
66. Molina R, Lohse JM, Pulido F, Laguna F, Lopez-Velez R, et al. (1999) Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus. Am J Trop Med Hyg 60: 51-53.
67. Leishman W (1903) On the possibility of the occurrence of trypanosomiasis in India. British Medical Journal 1: 1252-1254.
68. Donovan C (1903) The etiology of heterogeneous fevers in India. Lancet 2: 1401.
69. Bora D (1999) Epidemiology of visceral leishmaniasis in India. Natl Med J India 12: 62-68.
70. Sanyal RK (1985) Leishmaniasis in the Indian sub-continent. In: Chang KP, Bray RS, eds. Leishmaniasis. Amsterdam: Elsevier Science Publishers, B.V, pp 443-467.
71. Ahluwalia IB, Bern C, Costa C, Akter T, Chowdhury R, et al. (2003) Visceral leishmaniasis: Consequences of a neglected disease in a Bangladeshi community. American Journal of Tropical Medicine and Hygiene 69: 624-628.
72. Thakur CP, Kumar K, Sinha PK, Mishra BN, Pandey AK (1987) Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate. Br Med J (Clin Res Ed) 295: 886-887.
73. Sharma DA, Bern C, Varghese B, Chowdhury R, Haque R, et al. (2006) The economic impact of visceral leishmaniasis on households in Bangladesh. Trop Med Int Health 11: 757-764.
74. Thakur CP (1984) Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar denial leishmaniasis). Trans R Soc Trop Med Hyg 78: 391-398.
75. Ahluwalia IB, Bern C, Wagatsuma Y, Costa C, Chowdhury R, et al. (2004) Visceral leishmaniasis: Consequences to women in a Bangladeshi community. J Womens Health (Larchmt) 13: 360-364.
76. Thakur CF (2000) Socio-economics of visceral leishmaniasis in Bihar (India). Transactions of the Royal Society of Tropical Medicine and Hygiene 94: 156-157.
77. Adhikari SR, Maskay NM (2003) The economic burden of Kala-azar in households of the Danusha and Mahottari districts of Nepal. Acta Tropica 88: 1-2.
78. Rijal S, Koirala S, Van der Stuyft P, Boelaert M (2006) The economic burden of visceral leishmaniasis for households in Nepal. Trans R Soc Trop Med Hyg.
79. Meheus F, Boelaert M, Baltussen R, Sundar S (2006) Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med Int Health 11: 1715-1724.
80. Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6: 849-854.
81. Sundar S, More DK, Singh MK, Singh VP, Sharma S, et al. (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic. Clin Infect Dis 31: 1104-1107.
82. Brasil Ministério da Saúde (2006) Manual de Vigilância e Controle da Leishmaniose Visceral. Brasilia, Brasil: Brasil Ministério da Saúde, Secretaria de Vigilância em Saúde. 182 p.
83. Costa CH, Pereira HF, Araujo MV (1990) [Visceral leishmaniasis epidemic in the State of Piaui, Brazil, 1980-1986]. Rev Saude Publica 24: 361-372.
84. World Health Organization (2002) Urbanization: An increasing risk factor for visceral leishmaniasis. Weekly Epidemiological Record 77: 365-370.
85. Arias JR, Monteiro PS, Zicker F (1996) The reemergence of visceral leishmaniasis in Brazil. Emerg Infect Dis 2: 145-146.
86. Costa CH, Werneck GL, Rodrigues L Jr, Santos MV, Araujo IB, et al. (2005) Household structure and urban services: Neglected targets in the control of visceral leishmaniasis. Ann Trop Med Parasitol 99: 229-236.
87. Werneck GL, Costa CH, Walker AM, David JR, Wand M, et al. (2007) Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol Infect 135: 195-201.
88. Jeronimo SM, Oliveira RM, Mackay S, Costa RM, Sweet J, et al. (1994) An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg 88: 386-388.
89. Rabello A, Orsini M, Disch J (2003) Leishmania/HIV co-infection in Brazil: An appraisal. Ann Trop Med Parasitol 97 Suppl 1: 17-28.
90. World Health Organization (2007) Leishmaniasis and HIV co-infection. Geneva, Switzerland.
91. Dantas-Torres F, Brandao-Filho SP (2006) [Geographical expansion of visceral leishmaniasis in the State of Pernambuco]. Rev Soc Bras Med Trop 39: 352-356.
92. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C (2002) Infectiousness in a cohort of brazilian dogs: Why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 186: 1314-1320.
93. Barão SC. de Fonseca Camargo-Neves VL. Resende MR, da Silva LJ (2007) Human asymptomatic infection in visceral leishmaniasis: A seroprevalence study in an urban area of low endemicity. Preliminary results. Am J Trop Med Hyg 77: 1051-1053.
94. Instituto Nacional de Salud de Colombia (2006) Informe 2006 Leishmaniasis. Bogota, Colombia.
95. Llanos-Cuentas A, Tulliano G, Araujo-Castillo R, Miranda-Verastegui C, Santamaria-Castrellon G, et al. (2008) Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis 46: 223-231.
96. Davies CR, Llanos-Cuentas EA, Sharp SJ, Canales J, Leon E, et al. (1997) Cutaneous leishmaniasis in the Peruvian Andes: Factors associated with variability in clinical symptoms, response to treatment, and parasite isolation rate. Clin Infect Dis 25: 302-310.
97. Calvopina M, Armijos RX, Marco JD, Uezato H, Kato H, et al. (2006) Leishmania isoenzyme polymorphisms in Ecuador: Relationships with geographic distribution and clinical presentation. BMC Infect Dis 6: 139.
98. Rotureau B (2006) Ecology of the leishmania species in the Guianan ecoregion complex. Am J Trop Med Hyg 74: 81-96.
99. Tojal da Silva AC, Cupolillo E, Volpini AC, Almeida R, Romero GA (2006) Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health 11: 1388-1398.
100. Campbell-Lendrum D, Dujardin JP, Martinez E, Feliciangeli MD, Perez JE, et al. (2001) Domestic and peridomestic transmission of American cutaneous leishmaniasis: Changing epidemiological patterns present new control opportunities. Mem Inst Oswaldo Cruz 96: 159-162.
101. Brasil Ministério da Saúde (2000) Manual de Controle da Leishmaniose Tegumentar Americana. Brasilia, Brasil: Brasil Ministério da Saúde, Fundação Nacional de Saúde. 62 p.
102. Barrett TV, Senra MS (1989) Leishmaniasis in Manaus, Brazil. Parasitol Today 5: 255-257.
103. Alcais A, Abel L, David C, Torrez ME, Flandre P, et al. (1997) Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia. Am J Trop Med Hyg 57: 79-84.
104. Martinez F, Le Pont F, Torrez M, Telleria J, Vargas F, et al. (1998) A new focus of cutaneous leishmaniasis due to Leishmania amazonensis in a Sub Andean region of Bolivia. Acta Trop 71: 97-106.
105. Velez ID, Hendrickx E, Robledo SM, del Pilar Agudelo S (2001) [Gender and cutaneous leishmaniasis in Colombia]. Cad Saude Publica 17: 171-180.
106. Weigel MM, Armijos RX, Racines RJ, Zurita C, Izurieta R, et al. (1994) Cutaneous leishmaniasis in subtropical Ecuador: Popular perceptions, knowledge, and treatment. Bull Pan Am Health Organ 28: 142-155.
107. Davies CR, Reithinger R, Campbell-Lendrum D, Feliciangeli D, Borges R, et al. (2000) The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica 16: 925-950.
108. Vega JC, Sanchez BF, Montero LM, Montana R, Del Pilar Mahecha M, et al. (2007) Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004. Trop Med Int Health 12: 1540-1544.
109. Tayeh A, Jalouk L, Cairncross S (1997) Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg 91: 657-659.
110. World Health Organization (2002) Cutaneous leishmaniasis, Afghanistan. Wkly Epidemiol Rec 77: 246.
111. Hewitt S, Reyburn H, Ashford R, Rowland M (1998) Anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: Vertical distribution of cases in apartment blocks. Trans R Soc Trop Med Hyg 92: 273-274.
112. Reithinger R, Aadil K, Kolaczinski J, Mohsen M, Hami S (2005) Social impact of leishmaniasis, Afghanistan. Emerg Infect Dis 11: 634-636.
113. Thompson SK (1991) Stratified adaptive cluster sampling. Biometrika 78: 389-397.
114. Cattand P, Jannin J, Lucas P (2001) Sleeping sickness surveillance: An essential step towards elimination. Trop Med Int Health 6: 340-361.
115. King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4: 65-79.